Impaired immune responses in tuberculosis patients are related to weight loss that coexists with an immunoendocrine imbalance

NeuroImmunoModulation

Volumn 14, Issue 3-4, 2007, Pages 193-199

  Mahuad, Carolina ^a   Bozza, Verónica ^a   Pezzotto, Stella Maris ^a   Bay, María Luisa ^a   Besedovsky, Hugo ^b   Del Rey, Adriana ^b   Bottasso, Oscar ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Cytokines; Hormones; Immune response, impaired; Tuberculosis; Weight loss

Indexed keywords

ANTIGEN; CYTOKINE; GAMMA INTERFERON; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 6; LIOTHYRONINE; PRASTERONE; THYROID HORMONE; THYROXINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ALCOHOLISM; BODY MASS; BREATHING RATE; CALCULATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENDOCRINE SYSTEM; HEART RATE; HOST; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOENDOCRINE IMBALANCE; IN VITRO STUDY; LUNG TUBERCULOSIS; LYMPHOCYTE PROLIFERATION; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE; WEIGHT REDUCTION;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; CELLS, CULTURED; CYTOKINES; ENDOCRINE SYSTEM; ENDOCRINE SYSTEM DISEASES; HUMANS; HYDROCORTISONE; IMMUNE SYSTEM; IMMUNITY; IMMUNITY, NATURAL; IMMUNOCOMPROMISED HOST; INTERFERON TYPE II; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; THYROID HORMONES; TUBERCULOSIS; WEIGHT LOSS;

EID: 37048998942     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110646     Document Type: Conference Paper

References (35)

1. World Health Organization: WHO Report 2006: Global Tuberculosis Control - Surveillance, Planning, Financing. http://www.who.int/tb/publications/ global_report/2006/download_centre/en/index.html.
2. Flynn JL: Immunology of tuberculosis and implications in vaccine development. Tuberculosis 2004;84:93-101.
3. Ottenhoff TH, Verreck FA, Hoeve MA, van de Vosse E: Control of human host immunity to mycobacteria. Tuberculosis 2005;85:53-64.
4. Bottasso O, Bay ML, Besedovsky H, del Rey A: The immuno-endocrine component in the pathogenesis of tuberculosis. Scand J Immunol 2007;66:166-175.
5. Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, Dascher CC, Berezovskaya A, Rousset D, Reynes JM, Goldfeld AE: IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 2000;105:1317-1325.
6. Gong JH, Zhang M, Modlin RL, Linsley PS, Iyer D, Lin Y, Barnes PF: Interleukin-10 downregulates Mycobacterium tuberculosis induced Th1 responses and CTLA-4 expression. Infect Immun 1996;64:913-918.
7. Toossi Z, Gogate P, Shiratsuchi H, Young T, Ellner JJ: Enhanced production of TGF-β by blood monocytes from patients with active tuberculosis and presence of TGF-β in tuberculous granulomatous lung lesions. J Immunol 1995;154:465-473.
8. Palenicek J, Nelson KE, Vlahov D, Galai N, Cohn S, Saah AJ: Comparison of clinical symptoms of human immunodeficiency virus disease between intravenous drug users and homosexual men. Arch Intern Med 1993;153:1806-1812.
9. Davies PDO, Yew WW, Ganguly D, Davidow AL, Reichman LB, Dheda K, Rook GA: Smoking and tuberculosis:the epidemiological association and immunopathogenesis. Trans R Soc Trop Med Hyg 2006;100:291-298.
10. Brown KE, Campbell AH: Tobacco, alcohol and tuberculosis. Br J Dis Chest 1961;55:150-158.
11. Plata-Salaman CR: Cytokines and feeding. Int J Obesity 2001;25:S48-S52.
12. Langhans W: Anorexia of infection: current prospects. Nutrition 2000;16:996-1005.
13. Schwenk A, Macallan DC: Tuberculosis, malnutrition and wasting. Curr Opin Clin Nutr Metab Care 2000;3:285-291.
14. Boockvar KS, Granger DL, Poston RM, Maybodi M, Washington MK, Hibbs JB, Kurlander RL: Nitric oxide produced during murine listeriosis is protective. Infect Immun 1994;62:1089-1100.
15. Pearson RD, Cox G, Jeronimo SM, Castracane J, Drew JS, Evans T, de Alencar JE: Visceral leishmaniasis:a model for infection-induced cachexia. Am J Trop Med Hyg 1992;47:8-15.
16. Swiergiel AH, Dunn AJ: The roles of IL-1, IL-6, and TNFα in the feeding responses to endotoxin and influenza virus infection in mice. Brain Behav Immun 1999;13:252-265.
17. World Health Organization: Cardiomiopatías: Serie de Informes Técnicos, 697. Geneva, World Health Organization, 1984, pp 47-55.
18. Baumann H, Gauldie J: The acute phase response. Immunol Today 1994;15:74-80.
19. Hart BL: Behavioral adaptations to pathogens and parasites:five strategies. Neurosci Biobehav Rev 1990;14:273-294.
20. Rothman KJ: Causes. Am J Epidemiol 1976;104:587-592.
21. Tsujinaka T, Fujita J, Ebisui C, Yano M, Kominami E, Suzuki K, Tanaka K, Katsume A, Ohsugi Y, Shiozaki H, Monden M: Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J Clin Invest 1996;97:244-249.
22. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson JO: Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 2002;8:75-79.
23. Stenlof K, Wernstedt I, Fjallman T, Wallenius V, Wallenius K, Jansson JO: Interleukin-6 levels in the central nervous system are negatively correlated with fat mass in overweight/obese subjects. J Clin Endocrinol Metab 2003;88:4379-4383.
24. van Lettow M, van der Meer JWM, West CE, van Crevel R, Semba RD: Interleukin-6 and human immunodeficiency virus load, nut not plasma leptin concentration, predict anorexia and wasting in adults with pulmonary tuberculosis in Malawi. J Clin Endocrinol Metab 2005;90:4771-4776.
25. Besedovsky H, del Rey A: Immune-neuroendocrine interactions:facts and hypothesis. Endocr Rev 1996;17:64-102.
26. Dallman M, Strack A, Akana S, Bradbury M, Hanson E, Scribner K, Smith M: Feast and famine:critical role of glucocorticoids with insulin in daily energy flow. Front Neuroendocrinol 1993;14:303-347.
27. Tomas FM, Munro HN, Young VR: Effect of glucocorticoid administration on the rate of muscle protein breakdown in vivo in rats as measured by urinary excretion of N-taumethylhistidine. Biochem J 1979;178:139-146.
28. Nunez EA, Christeff N: Steroid hormones, cytokines, lipids and metabolic disturbances in HIV infection;in Norbiato G (ed): The Endocrinology and Metabolism of HIV Infection. London, Baillière Tindall, 1994, vol 8, pp 803-821.
29. Oertel GW, Benes P: The effect of steroids on glucose-6-phosphate dehydrogenase. J Steroid Biochem 1972;3:493-496.
30. Kellendonk C, Eiden S, Kretz O, Schutz G, Schmidt I, Tronche F, Simon E: Inactivation of the GR in the nervous system affects energy accumulation. Endocrinology 2002;143:2333-2340.
31. Albeck DS, McKittrick CR, Blanchard DC, Blanchard RJ, Nikulina J, McEwen BS, Sakai RR: Chronic social stress alters levels of corticotropin-releasing factor and arginine vasopressin mRNA in rat brain. J Neurosci 1997;17:4895-4903.
32. Bonneaud C, Mauc J, Gonzalez G, Haussey C, Chastel O, Faire B, Sorci G: Assessing the cost of mounting an immune response. Am Nat 2003;161:367-379.
33. Moret Y, Schmid-Hempel P: Survival for immunity: the price of immune system activation for bumblebee workers. Science 2000;290:1166-1168.
34. Lin HH, Ezzati M, Murray M: Tobacco smoke, indoor air pollution and tuberculosis:a systematic review and meta-analysis. PLoS Med 2007;4:e20.
35. Gamble L, Mason CM, Nelson S: The effects of alcohol on immunity and bacterial infection in the lung. Med Mal Infect 2006;36:72-77.